Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02448303
Brief Title: Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer (KEYNOTE166)

First Submitted : May 14, 2015
First Submitted that Met QC Criteria : May 15, 2015
First Posted : May 19, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 30, 2016
Last Update Posted : December 1, 2016 (Estimate)